At 7.3% CAGR, Europe Osteoarthritis Therapy Market is Projected to be Worth US$ 8,743.93 Million by 2030, says Business Market Insights

According to Business Market Insights' research, the Europe osteoarthritis therapy market was valued at US$ 4,971.51 million in 2022 and is expected to reach US$ 8,743.93 million by 2030, registering a CAGR of 7.3% from 2022 to 2030. Rising prevalence of osteoarthritis and innovative therapy options reducing dependency on medications are among the critical factors attributed to drive the Europe osteoarthritis therapy market growth.

The non-pharmacologic therapy is a key facet of treating OA. With lifestyle changes and medicines, patients suffering from OA may benefit from various supportive therapy options, including hot or cold packs and assistive devices. Additionally, complementary, and alternative therapy options such as nutritional supplements and rubefacients may help in managing OA. Further, topical treatments, supervised exercises, neuromuscular training, self-management, patient education, and weight loss intervention are among the best treatments suited for OA. In osteoarthritis knee pain (OKP) treatment, knee braces are used to reduce knee pain as these braces may apply compression (pressure) to soft tissues, stabilize the knee, and redistribute weight. A few examples of knee braces are compression sleeves, hinged knee braces, and unloader knee braces. Also, these compression braces are easily available at drugstores, pharmacies, and online channels. Therefore, availability of innovative therapy options reduces dependency on medications, which drives the osteoarthritis therapy market growth.

On the contrary, the product recall hampers the growth of Europe osteoarthritis therapy market.

Based on therapy type, the Europe osteoarthritis therapy market is segmented into transcutaneous electrical nerve stimulation (TENS), occupational therapy, physical therapy, platelet-rich plasma (PRP) therapy & stromal vascular fraction, prolotherapy, and others. The physical therapy segment held 42.9% market share in 2022, amassing US$ 2,130.49 million. It is projected to garner US$ 3,843.79 million by 2030 to register 7.7% CAGR during 2022-2030.

In terms of disease indications, the Europe osteoarthritis therapy market is segmented into knee osteoarthritis, spine osteoarthritis, foot and ankle osteoarthritis, shoulder osteoarthritis, hand osteoarthritis, and others. The knee osteoarthritis segment held 52.5% share of Europe osteoarthritis therapy market in 2022, amassing US$ 2,609.21 million. It is anticipated to garner US$ 4,679.39 million by 2030 to expand at 7.6% CAGR during 2022-2030.

Based on end user, the Europe osteoarthritis therapy market is categorized into hospitals and clinics, specialty clinics, ambulatory surgical center, homecare, and others. The homecare segment held 32.5% share of Europe osteoarthritis therapy market in 2022, amassing US$ 1,613.31 million. It is predicted to garner US$ 2,730.66 million by 2030 to expand at 6.8% CAGR between 2022 and 2030.

Based on country, the Europe osteoarthritis therapy market is categorized into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 28.9% share of Europe osteoarthritis therapy market in 2022. It was assessed at US$ 1,438.76 million in 2022 and is likely to hit US$ 2,618.54 million by 2030, registering a CAGR of 7.8% during 2022-2030.

Key players operating in the Europe osteoarthritis therapy market are Zimmer Biomet Holdings Inc, DePuy Synthes Inc, Bioventus Inc, Omron Healthcare Inc, Exactech Inc, and Medi GmbH & Co KG, among others.

• In March-2022, VQ OrthoCare introduced the OActive Align Osteoarthritis Knee Brace. The OActive Align offers clinicians an easy solution for custom-fitting and aligning the brace to produce exceptional patient outcomes. The brace employs a unique combination of features that precisely fit the anatomy, align the brace hinge axis, and secure it in its most effective position for corrective pain relief.
  
  

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com